Physician

Alma Rosibel Cruz, MD

According to 2025 Medicare claims, Alma Cruz, MD (NPI: 1699181966) practices allergy/immunology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is ASTHMA & ALLERGY ASSOCIATES OF FL PA (NPI: 1972687556; TIN: 650430484) and primary practice location at 33324-2321. Cruz is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Cruz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 27 traditional Medicare patients, billed 2,339 HCPCS/CPT codes, and received $49,272 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 674 prescription claims across 121 beneficiaries totaling $214,293 in drug costs, led by Dupixent Pen (Dupilumab). 2023 DME data shows 11 claims. Open Payments data shows 66 records totaling $1,617. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,951 to $49,272. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $19,735 to $214,293. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$25K$49K2020 Medicare payment: $17,951 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $33,558 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $16,524 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $32,998 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $49,272 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020201,262$17,951
2021511,993$33,558
2022521,378$16,524
2023361,824$32,998
2024272,339$49,272

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$250K$501K2018 Drug cost: $19,735 (USD; Tot_Drug_Cst)2019 Drug cost: $500,701 (USD; Tot_Drug_Cst)2020 Drug cost: $72,633 (USD; Tot_Drug_Cst)2021 Drug cost: $96,542 (USD; Tot_Drug_Cst)2022 Drug cost: $18,744 (USD; Tot_Drug_Cst)2023 Drug cost: $47,945 (USD; Tot_Drug_Cst)2024 Drug cost: $214,293 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182184$19,735
201931148$500,701
202045155$72,633
202170279$96,542
202253151$18,744
202371249$47,945
2024121674$214,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$17K$34K2023 Medicare payment: $33,974 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R11$33,974
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1218$86

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab15420$55,584
Trelegy ElliptaFluticasone/Umeclidin/Vilanter662,010$42,654
Breztri AerosphereBudesonide/Glycopyr/Formoterol19630$13,051
SymbicortBudesonide/Formoterol Fumarate291,230$8,534
Breo ElliptaFluticasone/Vilanterol15450$6,230

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.66$1,617GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alma Rosibel Cruz, MD?

Tedicare shows public-source Medicare data for Alma Rosibel Cruz, MD (NPI 1699181966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alma Rosibel Cruz, MD have ACO affiliation data?

Alma Rosibel Cruz, MD is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Alma Rosibel Cruz, MD?

Alma Rosibel Cruz, MD is linked to ASTHMA & ALLERGY ASSOCIATES OF FL PA (billing NPI 1972687556) in the available physician profile data.

Does Alma Rosibel Cruz, MD have Open Payments data?

Alma Rosibel Cruz, MD has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.